Skip to main content
. Author manuscript; available in PMC: 2016 Oct 21.
Published in final edited form as: Lab Invest. 2010 Oct 18;91(3):439–451. doi: 10.1038/labinvest.2010.172

Figure 4.

Figure 4

MMP elevation during hepatic fibrosis. (a) Zymogram using liver homogenates of wild-type and Dcn−/− mice without treatment (control), at 4 months of thioacetamide treatment (TA4), and at 4 months after the withdrawal of the chemical (TA4+4). (b,c) Quantification of zymograms as those shown in panel A using scanning densitometry. The values represent the mean intensity (%) ±SD of two experiments run in triplicate; **P<0.01